- GSK -1.24%
GSK and Ochre Bio link to explore liver disease drivers
Yahoo Finance · 1 day ago
Pfizer
Search results
- 40.60Add to watchlist-0.51 (-1.24%)As of Fri. Jun 14, 2024 1:20 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open40.82High40.87Low40.47
- Mkt Cap82.78BP/E (TTM)14.66Div & Yield1.50 & 3.66%
- Prev. Close41.1152 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesRelated stocks
June 10 2024 Statement: Zantac (ranitidine) litigation – Kasza case. June 07 2024 US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk. View all press releases.
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Find a GSK Program for You. Get started by answering a few questions. Learn how our program can assist you if you need help paying for your GlaxoSmithKline prescription medicines and vaccines, whether you have coverage or not.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
